Data Integration in Drug-Target Interaction Prediction for Drug Discovery and Drug Repositioning KU Leuven
Approved drugs have favorite or validated pharmacokinetic properties and toxicological profiles, and the repositioning of existing drugs for new indications can potentially avoid expensive costs associated with early-stage testing of the hit compounds. In recent years technological advances in virtual screening methodologies have allowed medicinal chemists to rapidly screen drug library for therapeutic activity against new biomolecular ...